Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.
L
L

Lonza

Balita

Reuters - 2 linggo ang nakaraan

Lonza Announces New Group Chief Executive Officer Wolfgang Wienand

BRIEF-Lonza Announces New Group Chief Executive Officer Wolfgang Wienand July 1 (Reuters) - LONZA GROUP AG LONN.S : WELCOMES NEW GROUP CHIEF EXECUTIVE OFFICER WOLFGANG WIENAND ALBERT M. BAEHNY WILL RETIRE FROM LONZA GROUP FOLLOWING A TRANSITION PERIOD WOLFGANG WIENAND COMMENCES HIS TENURE AS CHIEF EXECUTIVE OFFICER OF LONZA GROUP Source text for Ei
L
Reuters - 4 linggo ang nakaraan

ABB, Klepierre, Ryanair

EUROPE RESEARCH ROUNDUP-ABB, Klepierre, Ryanair June 20 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including ABB, Klepierre and Ryanair, on Thursday. HIGHLIGHTS * ABB Ltd ABBN.S : Citigroup cuts to neutral from buy * ASM International NV ASMI.AS : Morgan Stanley raises to overweight from equal weight * Deutsche Lufthansa AG LHAG.DE : Stifel cuts to hold from buy * Klepierre LOIM.PA : HSBC raises to buy from hold * Ryanair RYA.I : UBS cu
A
A
B
C
D
D
G
K
K
L
L
L
M
N
N
P
S
W
A
A
A
L
R
S
Reuters - 1 buwan ang nakaraan

AB Dynamics, Etteplan, Wise

EUROPE RESEARCH ROUNDUP-AB Dynamics, Etteplan, Wise June 14 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including AB Dynamics, Etteplan and Wise, on Friday. HIGHLIGHTS * AB Dynamics Plc ABDP.L : Berenberg re-initiates coverage With Buy rating; PT 2,620p * Crest Nicholson CRST.L : Barclays cuts target price to 230p from 258p * Etteplan Oyj ETTE.HE : Evli Research raises to buy from hold * Halma HLMA.L : Barclays raises target price to 284
B
C
E
H
H
J
L
O
O
P
R
S
S
T
U
V
V
Z
H
A
R
Reuters - 1 buwan ang nakaraan

Asmi, Beiersdorf, SSE

EUROPE RESEARCH ROUNDUP-Asmi, Beiersdorf, SSE June 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Asmi, Beiersdorf and SSE, on Friday. HIGHLIGHTS * Arcadis NV ARDS.AS : KBC Securities raises to accumulate from buy * Asmi ASMI.AS : Berenberg raises target price to EUR 720 from EUR 640 * Beiersdorf BEIG.DE : HSBC raises target price to EUR 158 from EUR 152 * Nibe Industrier AB NIBEB.ST : HSBC cuts to hold from buy * SSE SSE.L : HS
A
B
B
C
D
E
E
I
J
L
L
S
W
Reuters - 1 buwan ang nakaraan

Asmi, Beiersdorf, SSE

CORRECTED-EUROPE RESEARCH ROUNDUP-Asmi, Beiersdorf, SSE Corrects Greenyard NV entry to say KBC Securities raises target price to EUR 9.5 from EUR 8.5 (not 6.30) and Arcadis NV entry to say KBC Securities cuts (not raises) to 'accumulate' from 'buy'; raises target price to EUR 66 from EUR 61 (not 61.7 June 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Asmi, Beiersdorf and SSE, on Friday.
A
B
B
B
C
D
D
E
E
I
J
K
L
L
P
R
S
V
V
V
W
P
S
Reuters - 2 buwan ang nakaraan

Swiss pharma supplier Lonza reports softer Q1 but confirms outlook

UPDATE 1-Swiss pharma supplier Lonza reports softer Q1 but confirms outlook Adds outlook in paragraph 1, info about Biosecure Act in paragraph 5-6, CFO quote in paragraph 7 By Chiara Holzhaeuser and Tristan Veyet May 14 (Reuters) - Swiss pharmaceutical supplier Lonza LONN.S reported a "softer Q1" on Tuesday, while confirming its 2024 outlook, saying its lacklustre performance was mainly due to the phasing of commercial batches and a weaker start at its bioscience business.
B
L
Reuters - 2 buwan ang nakaraan

Swiss pharma supplier Lonza flags signs of recovery in biotech funding

Swiss pharma supplier Lonza flags signs of recovery in biotech funding May 14 (Reuters) - Swiss pharmaceutical supplier Lonza LONN.S confirmed its 2024 outlook on Tuesday, flagging early signs of recovery in biotech funding even as clinical demand in its biologics division remained soft in the first quarter. It said commercial performance was positive across its biologics, small molecules, and cell & gene businesses in the quarter, while development in its capsules & health ingredients unit was
B
L
Reuters - 2 buwan ang nakaraan

Lonza Group Confirms 2024 Outlook

BRIEF-Lonza Group Confirms 2024 Outlook May 14 (Reuters) - LONZA GROUP AG LONN.S : PERFORMANCE IN LINE WITH EXPECTATIONS FOR FULL-YEAR 2024 H2 SALES EXPECTED TO BE SOLID CONFIRMS OUTLOOK 2024 Source text for Eikon: ID:nSN6xhSvm Further company coverage: LONN.S (Gdansk Newsroom)
L
Reuters - 2 buwan ang nakaraan

Swiss stocks - Factors to watch on May 14

Swiss stocks - Factors to watch on May 14 ZURICH/BERLIN, May 14 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Tuesday: UBS UBSG.S UBS CEO Sergio Ermotti warned on Monday that any delay to the integration of its technology and data with those of former rival Credit Suisse would erode planned cost savings, as he vowed to see the process through and stay on until 2027. GLENCORE GLEN.L Australia's Queensland state will decide this month whether to give Glencore a key
A
G
L
S
S
U
Reuters - 2 buwan ang nakaraan

Swiss stocks - Factors to watch on May 13

Swiss stocks - Factors to watch on May 13 ZURICH/BERLIN, May 13(Reuters) - Here are some of the main factors that may affect Swiss stocks on Monday: NESTLE NESN.S Media/Bloomberg - PAI to delay exit from 10 million dollar ice cream joint venture. KL 1 Together with the German aviation firm Lilium 5KD.F , the company will set up new sites in France in a combined investment of 700 million euros.
A
L
N
S
S
Reuters - 2 buwan ang nakaraan

Adecco Group, Centrica, UBS

EUROPE RESEARCH ROUNDUP-Adecco Group, Centrica, UBS May 8 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adecco Group, Centrica and UBS, on Wednesday. HIGHLIGHTS * Adecco Group AG ADEN.S : RBC raises to outperform from sector perform * Centrica CNA.L : UBS raises to buy from neutral * Direct Line Insurance DLGD.L : Morgan Stanley resumes coverage with equal-weight rating * Lindt & Spruengli LISN.S : Barclays raises to equal weight
A
A
A
A
A
A
B
B
B
B
B
C
D
E
G
H
H
I
K
L
L
L
S
S
S
V
A
A
B
B
D
D
M
Reuters - 2 buwan ang nakaraan

Swiss stocks - Factors to watch on May 8

Swiss stocks - Factors to watch on May 8 ZURICH/BERLIN, May 8(Reuters) - Here are some of the main factors that may affect Swiss stocks on Wednesday: COMPANY STATEMENTS * Talenthouse THAGN.S - Postponement Of Publication Of The Annual Report 2023 Until 31 May 2024 * EDAG Engineering Group ED4.DE - Harald Keller Appointed CEO As Of July 01, 2024 * Garrett Motion G02.F - Upsizing And Pricing Of Private Offering Of $800 Million Of Senior Notes Due 2032 ANNUAL GENERAL MEETINGS ALCON AG ALCC.S - 0.24
A
K
L
S
Reuters - 3 buwan ang nakaraan

Roche to review manufacturing further after sale of site to Lonza, CEO says

Roche to review manufacturing further after sale of site to Lonza, CEO says FRANKFURT, April 24 (Reuters) - Roche ROG.S will further review its manufacturing network after the sale of a major site to Lonza LONN.S last month because biotech production technology has become much more efficient. Speaking after the release of quarterly sales, CEO Thomas Schinecker said the Swiss group has the largest manufacturing capacity in the pharma industry and it needs to adapt because technology upgrades in s
L
R
Reuters - 3 buwan ang nakaraan

Swiss stocks - Factors to watch on April 18

Swiss stocks - Factors to watch on April 18 ZURICH/BERLIN, Apr 18(Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday: UBS AG UBSG.S UBS Group is planning another round of job cuts after its takeover of Credit Suisse that is expected to affect over a hundred positions across the group's global investment bank, Bloomberg News reported on Wednesday.
A
L
N
S
U
Reuters - 3 buwan ang nakaraan

Lonza Prices EUR 1 Bln Straight Bond With 3.875% Coupon

BRIEF-Lonza Prices EUR 1 Bln Straight Bond With 3.875% Coupon April 17 (Reuters) - Lonza Group AG LONN.S : LONZA PRICES EUR 1 BILLION STRAIGHT BOND WITH A 3.875% COUPON BOND HAS A MATURITY OF 12 YEARS AND AN ANNUAL COUPON OF 3.875% Source text for Eikon: ID:nEQ4MCSfYa Further company coverage: LONN.S
L

Kundisyon

Mga Patok na Assets

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.